CTC
ALNY icon

Cetera Trust Company’s Alnylam Pharmaceuticals ALNY Stock Holding History

Cetera Trust Company’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.82K Hold
16
– – ﹤0.01% 332
2026
Q1 		$5.29K Hold
16
– – ﹤0.01% 334
2025
Q4 		$6.36K Hold
16
– – ﹤0.01% 329
2025
Q3 		$7.3K Hold
16
– – ﹤0.01% 320
2025
Q2 		$5.22K Hold
16
– – ﹤0.01% 339
2025
Q1 		$4.32K Hold
16
– – ﹤0.01% 353
2024
Q4 		$3.77K Hold
16
– – ﹤0.01% 375
2024
Q3 		$4.4K Hold
16
– – ﹤0.01% 379
2024
Q2 		$3.89K Hold
16
– – ﹤0.01% 386
2024
Q1 		$2.39K Hold
16
– – ﹤0.01% 409
2023
Q4 		$3.06K Buy
+16
New +$2.73K ﹤0.01% 406

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cetera Trust Company's ALNY Position: Q2 2026 in Review

Cetera Trust Company held its Alnylam Pharmaceuticals (ALNY) position steady in Q2 2026 at 16 shares worth $4.82K. The position accounts for ﹤0.01% of the portfolio, ranked #332.

Cetera Trust Company first reported a position in ALNY in Q4 2023 and has held it in 11 quarters since. The position peaked at $7.3K in Q3 2025. 791 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Cetera Trust Company held 16 shares of Alnylam Pharmaceuticals worth $4.82K as of Q2 2026.
  • Cetera Trust Company left its Alnylam Pharmaceuticals share count unchanged in Q2 2026.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Cetera Trust Company's portfolio in Q2 2026, its #332 holding.
  • Cetera Trust Company first reported a position in Alnylam Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • Cetera Trust Company's Alnylam Pharmaceuticals position peaked at $7.3K in Q3 2025.
  • 791 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Cetera Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.